Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT [Yahoo! Finance]
Krystal Biotech, Inc. (KRYS)
Last krystal biotech, inc. earnings: 11/4 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.krystalbio.com/investors
Company Research
Source: Yahoo! Finance
ISI's Gavin Clark-Gartner affirmed a Buy rating on Krystal Biotech, Inc. (NASDAQ:KRYS) stock and set a price target of $218. Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT In a different update, Krystal released its Q3 2025 results on November 3, in which the quarter's EPS came in at $2.66 per diluted share against the anticipated $1.09. Revenue touched $97.8 million from its VYJUVEK product, bringing total revenue since the US launch to over $623 million. The quarter's net income was $79.4 million. According to management, this growth was driven by manufacturing efficiencies and a one-time non-cash tax benefit. Also, gross margin improved to 96% during the quarter, up from 93% in the prior quarter due to US product manufacturing optimizations, as noted by management. As a result, the company ended the quarter with over $864 million in cash and investments. In terms of operations, management emphasized that expansion into Germany, France, and Japan is
Show less
Read more
Impact Snapshot
Event Time:
KRYS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRYS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRYS alerts
High impacting Krystal Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
KRYS
News
- Krystal Biotech (NASDAQ:KRYS) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Krystal Biotech to Present at 8th Annual Evercore Healthcare ConferenceGlobeNewswire
- Krystal Biotech: Vyjuvek Gene Therapy Well Positioned For Growth [Seeking Alpha]Seeking Alpha
- Krystal Biotech (NASDAQ:KRYS) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
KRYS
Earnings
- 11/3/25 - Beat
KRYS
Sec Filings
- 12/4/25 - Form 144
- 12/4/25 - Form 144
- 11/3/25 - Form 8-K
- KRYS's page on the SEC website